XERS
Xeris Pharmaceuticals Inc
9.60$
-4.2%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | +34.2% | +166.7% | -9.2% | +0.0% | +179.3% | +13.2% | -6.4% | +0.1% | +18.7% | |
| – | +32.8% | +167.6% | -25.8% | +0.0% | +63.0% | +31.0% | -16.4% | +7.3% | +43.3% | |
| – | +30.3% | +8.7% | -57.3% | +0.0% | +244.6% | +81.3% | -44.7% | +6.2% | +55.0% | |
| – | +30.3% | +167.9% | -32.9% | +0.0% | +35.6% | +19.1% | -40.6% | -1.1% | +55.0% | |
| – | +1,087.1% | +139.3% | +96.5% | -16.8% | +272.0% | +76.6% | +27.1% | +3.1% | +26.3% | |
| – | – | – | – | +0.0% | +732.6% | +36.5% | +57.0% | +24.0% | +42.5% | |
| – | +152.6% | +158.1% | +286.1% | -14.6% | -1.2% | +43.5% | – | – | – | |
| – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | – | – | – | – | -8.2% | -9.0% | -9.9% | -11.0% | |
| – | +57.1% | -56.6% | +111.9% | +0.0% | +121.2% | +43.1% | +10.0% | +7.1% | +4.9% | |
| – | +92.3% | +109.3% | +168.8% | +0.0% | +189.1% | -6.9% | +29.3% | +5.5% | +9.1% | |
| – | +183.5% | +221.2% | – | – | – | +0.0% | +121.2% | +506.1% | -70.6% | |
| – | +50.3% | -56.2% | +547.0% | +0.0% | +59.3% | -48.4% | +151.1% | -80.2% | +34.3% | |
| – | – | – | +82.8% | +49.3% | +1.2% | +112.4% | +2.1% | +13.7% | +1.5% | |
| – | – | – | -80.9% | +0.0% | +559.7% | -52.6% | -115.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +10.1% | +493.9% | +116.8% | +0.0% | +202.7% | +71.6% | +1.5% | +6.6% | +17.7% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.